Back
BridgeBio Pharma, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
BBIO
BridgeBio Pharma, Inc.
Last Price:
$70.14
Seasonality Move:
3.29%
7 Day Trial
ALL ACCESS PASS
$
7
BridgeBio Pharma, Inc. Stock Forecast
-
Over the next 52 weeks, BridgeBio Pharma, Inc. has on average historically risen by 66.7% based on the past 6 years of stock performance.
-
BridgeBio Pharma, Inc. has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%
-
Is BridgeBio Pharma, Inc. Stock Undervalued?The current BridgeBio Pharma, Inc. [BBIO] share price is $70.12. The Score for BBIO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BridgeBio Pharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BridgeBio Pharma, Inc. has on average historically risen by 66.7% based on the past 6 years of stock performance.
BridgeBio Pharma, Inc. Stock Rating
Sell
40
BridgeBio Pharma, Inc. (BBIO)
is a Sell
Is BridgeBio Pharma, Inc. overpriced?
-
BridgeBio Pharma, Inc. has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%
BridgeBio Pharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com
52-Week Data
52-Week High:
84.94
52-Week Low:
28.33
Prediction Charts
Market Cap:
13.6B
Price in USD:
70.12
Volume:
1.4M
Beta:
1.07
Technical Analysis
SMA50:
72.71
SMA100:
71.11
SMA200:
59.61
52-Wk Change:
117.83%
Stock Predictions
-
Is BridgeBio Pharma, Inc. stock public?Yes, BridgeBio Pharma, Inc. is a publicly traded company.
-
What is the BridgeBio Pharma, Inc. stock quote today?The BridgeBio Pharma, Inc. stock price is 70.12 USD today.
-
How to buy BridgeBio Pharma, Inc. stock online?You can buy BridgeBio Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-27 | 66.42 | 66.48 | 68.47 | 65.46 |
| Mar-2 | 64.36 | 65.50 | 65.67 | 63.35 |
| Mar-3 | 63.74 | 64.53 | 65.83 | 62.77 |
| Mar-4 | 65.00 | 66.54 | 67.20 | 64.26 |
| Mar-5 | 65.71 | 66.17 | 66.58 | 64.71 |
| Mar-6 | 64.41 | 65.36 | 66.06 | 63.63 |
| Mar-9 | 65.17 | 65.64 | 66.37 | 64.50 |
| Mar-10 | 66.12 | 74.32 | 75.91 | 66.00 |
| Mar-11 | 73.16 | 71.39 | 74.15 | 70.81 |
| Mar-12 | 70.35 | 67.98 | 70.36 | 67.85 |
| Mar-13 | 68.81 | 69.41 | 70.00 | 67.73 |
| Mar-16 | 70.45 | 71.03 | 71.98 | 70.09 |
| Mar-17 | 70.18 | 70.94 | 71.56 | 69.91 |
| Mar-18 | 70.94 | 70.12 | 71.33 | 69.82 |
BridgeBio Pharma, Inc. Earnings
BridgeBio Pharma, Inc. Earnings Report: Per Share BridgeBio Pharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BridgeBio Pharma, Inc. Forecast Revenue Growth
BridgeBio Pharma, Inc. Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.
* BridgeBio Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.